Background: We aimed at investigating the risk of bladder cancer at different levels of alcohol consumption by conducting a meta-analysis of epidemiological studies.
introduction Alcohol drinking accounts for over 5% of male and 1.7% of female cancer cases worldwide [1] . A causal association between alcohol consumption and cancers of the oral cavity and pharynx, oesophagus, colorectum, liver, larynx and breast is established [2] . A growing amount of evidence also indicates a positive association between elevated alcohol consumption and pancreatic cancer [3, 4] .
For other cancer sites, there is no established association with alcohol. Several studies considered the relation between alcohol drinking and bladder cancer. Though most of them reported no association, results were often inconsistent [2, 5] . In fact, investigations conducted in selected European and American countries reported increases in bladder cancer risk, particularly in men [6] [7] [8] [9] . This has been explained by the different correlates-including mainly tobacco but also coffee and diet-of alcohol consumption in various countries, and thus by potential residual confounding [2, 5] . The World Cancer Research Fund (WCRF) Second Expert Report, published in 2007, concluded that the data were too inconsistent to allow any conclusion on the relation between alcohol and bladder cancer [10] .
A meta-analysis of alcohol and cancer risk conducted in 2001 [11] , based on 11 studies and 6000 cases of bladder cancer, reported pooled relative risks (RRs) of bladder cancer of 1.04 [95% confidence interval (CI) 0.99-1.09] for alcohol intake of 25 g/day, 1.08 (95% CI 0.98-1.19) for 50 g/day and 1.17 (95% CI, 0.97-1.41) for 100 g/day. A more recent meta-analysis [12] , based on 18 studies, found a pooled odds ratio (OR) of 1.00 (95% CI 0.89-1.10) for alcohol drinkers versus non-drinkers, and an inverse association with beer (OR = 0.86; 95% CI 0.76-0.96) and wine consumption (OR = 0.85; 95% CI 0.71-1.00). The latter study was mainly focused on the role of different types of alcoholic beverages on bladder cancer, while the doserisk relation with total alcohol was not examined.
With the aim to investigate the risk of bladder cancer at different levels of total alcohol consumption, we carried out a meta-analysis of epidemiological studies published up to October 2010.
materials and methods
The meta-analysis was conducted following the guidelines developed by the Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group [13] . In October 2010, two authors (CP and CG) carried out a systematic literature search in the Medline database, using PubMed, for all studies published in English, using the following search string: ( Two of the authors (CG and LS) retrieved and assessed potentially relevant articles and checked the reference list of all papers of interest to obtain other pertinent publications. Figure 1 gives the flowchart for selection of articles. A total of 285 publications were identified in the search. Among them, 244 did not report original epidemiological results on the relation between alcohol drinking and bladder cancer and were no longer considered, whereas the remaining 41 publications were retained for the review. The review of the reference lists of these publications and of earlier reviews and meta-analyses [5, 11, 12] resulted in the identification of eight additional reports. Each publication identified in this process was reviewed and included in the analysis if the following criteria were met: case-control and cohort studies considering at least three levels of alcohol consumption and reporting the estimates of the OR or RR and the corresponding CI-or information sufficient to calculate them-for each exposure level. Studies that met the above criteria but reported only information on specific types of alcoholic beverages were not included. Further, when multiple reports were published on the same study population, we included in the metaanalysis only the most informative one. Thus, the present analyses are based on 19 studies: 16 case-control [7, 8, [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] ] and 3 cohort [9, 28, 29] studies.
We reviewed all the studies and abstracted the following information in a standard format: study design, country, period of enrolment (casecontrol studies) and/or of follow-up (cohort studies), number of subjects (cases, controls or non-cases or cohort size), gender, covariates adjusted for in the analysis, risk estimates (ORs or RRs, collectively referred to as RRs) for categories of alcohol consumption and the corresponding 95% CIs, and, when available, the number of cases and non-cases for each level of alcohol consumption considered.
We used the midpoint of each category of alcohol consumption for each study. For upper open-ended exposure categories, we used 1.2-fold its lower bound [30] . These assumptions were decided a priori and were previously used in companion meta-analyses of alcohol drinking and cancer risk [4, 31] . Grams of ethanol were used as measure for the analyses, defining one drink as 12.5 g of ethanol, if not otherwise specified in the original report, 1 ml of alcohol as 0.8 g, and 1 oz as 28.35 g. We used non-drinkers as reference category. Therefore, one study reporting male data categorised according to quintiles of intake was not included in the analyses in men [17] . We defined moderate alcohol intake as <37.5 g of ethanol per day, i.e. <3 drinks per day, and heavy intake as ‡37.5 g of ethanol-i.e. ‡3 drinks-per day. When more than one estimate in a study fell in the range considered for moderate or heavy alcohol drinking, we pooled the Data on women were not included in the meta-analysis because information was provided for drinkers versus non-drinkers only. b Data on men were not included in the meta-analysis because the reference category included drinkers of up to 160 g/week of alcohol. c We included in the meta-analysis the combined data for men and women because information for women was provided for drinkers versus non-drinkers only.
M, men; MY, man-years; NC, non-cases; W, women; WY, woman-years.
original articles Annals of Oncology corresponding estimates using the Hamling et al. method [32] , thus taking into account their correlation. When available, we used multivariate-adjusted risk estimates. When RRs were not given in the published articles, we computed unadjusted RRs from the exposure distributions of cases and controls as reported in the publications.
One study [20] reported both combined and gender-specific RRs. Since results in women considered less than three levels of alcohol consumption (i.e. drinkers versus non-drinkers), we included in the meta-analysis the combined estimates for men and women.
We calculated summary estimates of the RR using random effects models [i.e. as weighed averages using the inverse of the sum of the variance of the log (RR) and the moment estimator of the variance between studies as weight] [33] . Heterogeneity between studies was assessed using the v 2 test.
We conducted sensitivity analyses by excluding each study at a time from the meta-analysis. We also computed summary estimates in strata of sex, study design, geographic area and adjustment for tobacco smoking. We draw forest plots, in which a square is plotted for each study, whose centre projection on the underlying scale corresponds to the study-specific RR. The area of each square is proportional to the study weight. A diamond is used to plot the summary RR, whose centre represents the RR and its extremes the 95% CI. Stata software v. 11.0 (StataCorp LP, College Station, TX) was used to produce the forest plots.
results Table 1 reports the main characteristics of the 19 studies included in the meta-analysis. There were 16 case-control studies (2 of those were nested in a cohort) and 3 cohort studies. Nine studies were conducted in America, eight in Europe and two in Japan. Five studies provided combined estimates for men and women only, eight studies genderspecific estimates only, one study both, four studies included men only and one study women only. Overall, this metaanalysis included 11 219 cases of bladder cancer (6108 men, 2009 women and 3102 cases in studies where men and women were analysed together). Fifteen out of 19 studies provided results adjusted for tobacco smoking, besides other covariates. Figure 2 shows the study-specific and pooled RRs and 95% CIs of bladder cancer for moderate, i.e. <3 drinks per day, versus no alcohol consumption. Six studies reported combined data for men and women at this consumption level, and the pooled RR was 0.90 (95% CI 0.73-1.12; P for heterogeneity = 0.05). Eleven studies reported data for males, with a pooled RR of 1.09 (95% CI 0.98-1.22; P for heterogeneity = 0.20), while seven studies had results for women, with a pooled RR of 0.91 (95% CI 0.76-1.09; P for heterogeneity = 0.11). When all the 24 estimates from 19 studies were pooled together, the RR was 1.00 (95% CI 0.92-1.09; P for heterogeneity = 0.02). In sensitivity analyses, we calculated pooled RRs after exclusion of one study at a time. No study had a notable influence on the overall estimate, the pooled RRs for moderate drinking varying between 0.98 (when excluding Slattery et al. [8] ) and 1.03 (when excluding Thomas et al. [22] ). Figure 3 shows the study-specific and pooled RRs and 95% CIs of bladder cancer for heavy, i.e. ‡3 drinks per day, versus no alcohol consumption. Four studies reported combined data for men and women, with a pooled RR of 0.72 (95% CI 0.60-0.88; P for heterogeneity = 0.64). Five studies reported data for males, with a pooled RR of 1.52 (95% CI 0.99-2.33; P for heterogeneity = 0.02), while one study had results for women (RR = 0.81, 95% CI 0.38-1.72). When all 10 estimates from 9 different studies were pooled together, the RR was 1.02 (95% CI 0.78-1.33; P for heterogeneity < 0.01). In sensitivity analyses, the pooled RRs for heavy drinking varied between 0.92 (when excluding Donato et al. [7] ) and 1.09 (when excluding Jiang et al. [18] ). Both estimates were not significant. Table 2 gives the pooled RRs and 95% CIs of bladder cancer at different levels of alcohol drinking in strata of selected factors. Considering the study design, the RRs for moderate drinkers were 1.07 (95% CI 0.85-1.36) among cohort and 0.99 (95% CI 0.89-1.09) among case-control studies. All the data on heavy drinkers were from case-control studies (RR = 1.02, 95% CI 0.78-1.33). Considering the geographic area, the RRs for moderate drinkers were 0.98 (95% CI 0.88-1.10) in American studies, 1.04 (95% CI 0.87-1.25) in European studies and 1.09 (95% CI 0.74-1.62) in Asian studies. The corresponding RRs for heavy drinking were 0.80 (95% CI 0.56-1.13), 1.54 (95% CI 0.84-2.82) and 0.88 (95% CI 0.51-1.53). Most studies (80%) provided smoking-adjusted results. The pooled RRs of the latter were 0.98 (95% CI 0.89-1.07) for moderate and 0.97 (95% CI 0.72-1.31) for heavy drinking. No significant heterogeneity was found between subgroups (all the P-values were >0.05).
discussion
A mechanistic role of alcohol in the aetiology of bladder cancer is plausible. In fact, components of alcoholic beverages and their metabolites are excreted through the urinary tract. In particular, acetaldehyde, the primary breakdown product of ethanol in the body, has been shown to cause damage to the DNA, is classified as carcinogenic to humans [3, 34] and has been detected in the urine [35] . On the other hand, alcoholic beverages have also a diuretic effect that may lead to higher frequency of voiding and thus decreased exposure of the bladder epithelium to carcinogens.
The findings of our meta-analysis complement each other with those of Mao et al. [12] . Our study was focused on the relation between different levels of alcohol drinking and bladder cancer, while Mao et al. [12] investigated the risk in drinkers (as compared with non-drinkers) of any alcoholic beverage and of beer, wine and spirits separately. Consequently, though the same number of studies was included in these two meta-analyses (n = 19), several studies had information satisfying the inclusion criteria of only one investigation and were thus not overlapping [14, 22, 25, 27, 29, [36] [37] [38] [39] [40] . Still, the overall findings of the two meta-analyses are consistent. The result from Mao et al. [12] that beer and wine might have an inverse dose-risk relation with bladder cancer was however not confirmed for total alcohol consumption in our investigation. Tobacco smoking is the major identified environmental risk factor for bladder cancer [41] and, in several populations, it is positively correlated with alcohol drinking. Therefore, the lower risks observed in studies adjusted for smoking habits as compared with unadjusted ones are not surprising. Similarly, if residual confounding from tobacco is present, this would lead to an overestimation of the RRs of alcohol. This strengthens the result of a lack of a positive association between alcohol and bladder cancer and may explain the RR being slightly above unity among heavy drinkers.
We reported somewhat higher pooled RRs in men than in women. However, the proportion of male subjects in studies providing combined estimates for men and women was high, 80% to 85% [8, 18, 20, 23] , and the pooled RRs in this subgroup were low (i.e. 0.90 for moderate and 0.72 for heavy drinking). When we considered data for men alone from the only study reporting combined and gender-specific RRs [20] , the pooled RR in male heavy drinkers declined from 1.52 to 1.29.
Findings for moderate drinking were similar in different geographic areas, while those for heavy drinking were somewhat higher in studies from Europe. These estimates were however based on a limited number of studies, were highly heterogeneous and, in fact, most of the increase in risk was explained in sensitivity analyses by one study alone reporting a strong association [7] . When we excluded that study, the pooled RR for European studies declined to 1.16 (95% CI 0.72-1.85), in broad agreement with results from other geographic areas. No increased risk was found in Japanese studies (RR = 0.88 for heavy drinkers). Asian populations have higher frequencies of ADH1B*2 and ALDH2*2 mutant alleles than Caucasians [42] . ADH1B and ALDH2 polymorphisms have been related to the risk of selected cancers, particularly of the upper aerodigestive tract, in alcohol drinkers [43] [44] [45] . Data on their role on bladder neoplasms are, however, scanty [25] .
In conclusion, this meta-analysis of epidemiological studies provides definite evidence on the absence of any material association between alcohol drinking and bladder cancer risk. This result was based on a total of 19 investigations and over 11 000 cases of bladder cancer. Even heavy consumption, i.e. ‡3 drinks per day, was not related to the risk of bladder cancer.
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